Trial Profile
Phase II trial of pelareorep [Reolysin] in combination with standard of care (surgery followed by radiotherapy and temozolomide) in adult patients with glioblastoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2015
Price :
$35
*
At a glance
- Drugs Pelareorep (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2015 New trial record